Long Chen

Dr. Long Chen

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2015 in Journal of Peptide Science
Verified
Journal Article
Closed access
PDF file
XTXibo Tian
Xibo Tian
FSFude Sun
Fude Sun
XZXi‐Rui Zhou
Xi‐Rui Zhou
SLShi-Zhong Luo
Shi-Zhong Luo
LCLong Chen
Long Chen

2 March 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
SXSong Xue
Song Xue
FZFan Zhou
Fan Zhou
TZTian Zhao
Tian Zhao
HZHuimin Zhao
Huimin Zhao
XWXuewei Wang
Xuewei Wang
SLShi-Zhong Luo
Shi-Zhong Luo
Liquid-liquid phase separation (LLPS) plays important roles in various cellular processes, facilitating membrane-less organelles construction, chromatin condensation, signal transduction on inner membrane and many other processes. Current perception is that LLPS relies on weak multivalent interactions and crowded environments intracellularly. In this study, we demonstrate that heparan sulfate can serve as a platform to induce the phase separation of basic fibroblast growth factor on cell surface. The phase separation model provides an alternative mechanism how bFGF is enriched to its receptors, therefore triggering the signaling transduction. The research provides insights on the mechanism how growth factors can be recruited to cell surface by heparan sulfate and execute their functions, extending people’s view on phase separation from intracellular to extracellular proteins at cellular level.

1 May 2018 in Toxicon
Verified
Journal Article
Closed access
WWWenbo Wu
Wenbo Wu
ZZZhiling Zhu
Zhiling Zhu
BLBingjie Li
Bingjie Li
ZLZhuqing Liu
Zhuqing Liu
LJLili Jia
Lili Jia
SLShi-Zhong Luo
Shi-Zhong Luo

1 August 2017 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
XZXi-Rui Zhou
Xi-Rui Zhou
YCYimeng Cao
Yimeng Cao
QZQiang Zhang
Qiang Zhang
XTXi-Bo Tian
Xi-Bo Tian
HDHe Dong
He Dong
SLShi-Zhong Luo
Shi-Zhong Luo

1 August 2016 in Biochimica et Biophysica Acta (BBA) - Biomembranes
Verified
Journal Article
Closed access
XZXi-Rui Zhou
Xi-Rui Zhou
QZQiang Zhang
Qiang Zhang
XTXi-Bo Tian
Xi-Bo Tian
YCYi-Meng Cao
Yi-Meng Cao
ZLZhu-Qing Liu
Zhu-Qing Liu
SLShi-Zhong Luo
Shi-Zhong Luo

26 June 2021 in Briefings in Bioinformatics
Verified
Journal Article
Open access
PDF file
PPPengfei Pei
Pengfei Pei
HQHongbo Qin
Hongbo Qin
JCJialin Chen
Jialin Chen
FWFengli Wang
Fengli Wang
CHChengzhi He
Chengzhi He
SLShi-Zhong Luo
Shi-Zhong Luo
Targeting the interaction between severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2)-receptor-binding domain (RBD) and angiotensin-converting enzyme 2 (ACE2) is believed to be an effective strategy for drug design to inhibit the infection of SARS-CoV-2. Herein, several ultrashort peptidase inhibitors against the RBD–ACE2 interaction were obtained by a computer-aided approach based on the RBD-binding residues on the protease domain (PD) of ACE2. The designed peptides were tested on a model coronavirus GX_P2V, which has 92.2 and 86% amino acid identity to the SARS-CoV-2 spike protein and RBD, respectively. Molecular dynamics simulations and binding free energy analysis predicted a potential binding pocket on the RBD of the spike protein, and this was confirmed by the specifically designed peptides SI5α and SI5α-b. They have only seven residues, showing potent antiviral activity and low cytotoxicity. Enzyme-linked immunosorbent assay result also confirmed their inhibitory ability against the RBD–ACE2 interaction. The ultrashort peptides are promising precursor molecules for the drug development of Corona Virus Disease 2019, and the novel binding pocket on the RBD may be helpful for the design of RBD inhibitors or antibodies against SARS-CoV-2.